After Hours Summary: DHRM +4.3%, VRNT +4.2%, THTI +2.7%, YOD -14.7%, ARTX -12.2%, CUI -9.1% following earnings/guidance
After Hours Gainers: Companies trading higher in after hours in reaction to earnings: - DHRM +4.3%, VRNT +4.2%, THTI +2.7%, LJPC +2.6%, NGLS +1.3%, EGAS +1.3%, BVX +1.3%
Companies trading higher in after hours in reaction to news: - DRTX +7.3% (confirmed FDA Advisory Committee unanimously recommended approval of Dalvance for the treatment of acute bacterial skin and skin structure infections), - AMRN +2.2% (co and Kowa Pharmaceuticals America announced a U.S. Co-Promotion agreement for Vascepa (icosapent ethyl) Capsules), - KGC +2.2% (released Tasiast expansion feasibility study: 3.1 million ounce increase in estimated mineral reserves to 9.6 million ounces), - FST +1.6% (announced pudate to credit facility), - DBLE +1.4% (announced changed to Escalera Resources; begins trading under ticker symbol 'ESCR' effective April 1; announces strategic update conference call), - GALT +1.2% (announced that first cohort results in co's Phase 1 trial reveal biomarker evidence of therapeutic effect on fibrosis and inflammation in NASH with advanced fibrosis)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: - YOD -14.7%, ARTX -12.2%, CUI -9.1%, KGJI -3.0%, CLDN -1.5%, XON -1.1%, KINS -0.9%
Companies trading lower in after hours in reaction to news: - MDCO -12.2% (trading lower following FDA Advisory Committee support for bacterial skin infection products from Durata (DRTX) and Cubist (CBST)), - MDVN -5.3% (named Rick Bierly Chief Financial Officer following retirement of Patrick Machado), - MDR -2.8% (announced public offering of 10 mln tangible equity units, each with a stated value of $25), - QCRH -0.9% (announced redemption of $15 mln of small business lending fund preferred stock)